CRISCUOLO, ELENA
 Distribuzione geografica
Continente #
EU - Europa 92
NA - Nord America 47
AS - Asia 19
AF - Africa 16
OC - Oceania 2
SA - Sud America 2
Totale 178
Nazione #
IT - Italia 60
US - Stati Uniti d'America 28
HN - Honduras 14
FR - Francia 12
HK - Hong Kong 10
ZA - Sudafrica 10
DE - Germania 6
SC - Seychelles 6
CA - Canada 5
CN - Cina 4
GB - Regno Unito 4
IQ - Iraq 4
RU - Federazione Russa 4
CZ - Repubblica Ceca 3
NL - Olanda 3
AU - Australia 2
BR - Brasile 2
VN - Vietnam 1
Totale 178
Città #
Milan 41
Pretoria 10
Los Angeles 6
Victoria 6
Columbus 5
Paris 5
Baghdad 4
Frankfurt am Main 4
London 4
Ottawa 4
Shanghai 4
Ancona 3
Rome 3
Segrate 3
Vimodrone 3
Amsterdam 2
Ashburn 2
Brasília 2
Canberra 2
Kaluga 2
Lawrenceville 2
Moscow 2
New York 2
North Palm Beach 2
Afragola 1
Aversa 1
Campobasso 1
Central 1
Chicago 1
Florence 1
Kelowna 1
L’Aquila 1
Osio Sopra 1
Tai Kok Tsui 1
Totale 133
Nome #
Viral Respiratory Pathogens and Lung Injury, file e0c35a4c-e476-5883-e053-d805fe0ac580 89
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases, file bc68787d-03a6-4953-935a-6389dfd0ef47 11
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion?, file e0c35a4b-e01f-5883-e053-d805fe0ac580 10
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines, file e0c35a4c-1148-5883-e053-d805fe0ac580 7
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome, file f2f2e8a0-b0f7-4e44-9953-22dbe10a61f8 7
The initial interplay between HIV and mucosal innate immunity, file 87a96f6d-4586-4af7-a8bc-0037e9152a19 6
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes, file e0c35a4c-108b-5883-e053-d805fe0ac580 6
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19, file c84dfef7-f68a-44be-98a7-58ba4cd9d06f 4
Editorial: Viral escape of mucosal immunity in sexually transmitted diseases, file ca48cbe7-1e1b-429c-9aaf-44b2e76da990 4
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models, file d3b8b171-b378-4e9c-87cb-6cab89f83c15 4
Alternative methods of vaccine delivery: An overview of edible and intradermal vaccines, file e0c35a4c-a0d2-5883-e053-d805fe0ac580 4
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis., file e0c35a4c-1146-5883-e053-d805fe0ac580 3
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis, file e0c35a4c-1891-5883-e053-d805fe0ac580 3
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II, file 5689f372-9ada-4163-98d7-fcdbff798e4f 2
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols, file e0c35a4c-a163-5883-e053-d805fe0ac580 2
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects, file e0c35a4c-b6f9-5883-e053-d805fe0ac580 2
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials, file e0c35a4c-d472-5883-e053-d805fe0ac580 2
The interferon landscape along the respiratory tract impacts the severity of COVID-19, file e0c35a4c-ea32-5883-e053-d805fe0ac580 2
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2, file 5269a73c-aedc-4083-8ed3-fa18b9badb81 1
Next Generation Vaccines for Infectious Diseases, file 5fa47464-2c21-412d-9338-60f68c7780b3 1
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation, file 6b4c4c95-787c-4f55-932a-3e0d690b6451 1
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge, file e0c35a4c-101b-5883-e053-d805fe0ac580 1
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection, file e0c35a4c-a2c2-5883-e053-d805fe0ac580 1
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021, file e0c35a4c-e28f-5883-e053-d805fe0ac580 1
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy, file e0c35a4c-e33a-5883-e053-d805fe0ac580 1
The interferon landscape along the respiratory tract impacts the severity of COVID-19, file e0c35a4c-ec59-5883-e053-d805fe0ac580 1
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection, file e0c35a4c-ec8b-5883-e053-d805fe0ac580 1
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19, file e0c35a4c-fa35-5883-e053-d805fe0ac580 1
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs, file e0c35a4c-ff1b-5883-e053-d805fe0ac580 1
Totale 179
Categoria #
all - tutte 462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 462


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/20213 1 0 0 0 0 1 0 0 0 1 0 0
2021/20227 0 3 1 1 0 0 1 0 1 0 0 0
2022/2023139 0 4 8 3 10 7 30 24 15 14 22 2
2023/202429 0 0 0 4 0 0 0 2 4 2 12 5
Totale 179